All News

In a recent webinar sponsored by Drug Topics, pharmacy and insurance industry experts discuss the true impact of recent PBM reform efforts on the greater drug supply chain.

Pharmacists have the expertise to address acute and chronic pain distinctions, missed-dose protocols, tolerance and safety insights, and multimodal, non-pharmacological strategies for pain.

The 2026 guidance emphasizes that selecting newer and innovative agents should occur early, dependent on comorbidities of the patient.

The FDA’s Pharmacy Compounding Advisory Committee will meet in late July of 2026 to convene on peptides and their inclusion on the 503A Bulk Drug Substances List.

A head-to-head trial shows a protein-based COVID-19 booster causes fewer adverse effects, boosting patient preference and aiding pharmacists.

In an evolving pharmacy landscape, accreditation can be difficult to manage, which is why experts like Mitch Lamb, PharmD, can steer businesses onto their desired paths.

Under a 12-month agreement, the Utah authorities granted companies permission to use generative AI to authorize medication refills for state residents.

This proposed rule builds on previous CMS guidance from 2020 and 2024.

FDA expands Tzield use to age 1 year to delay stage 3 type 1 diabetes, enabling earlier immune intervention.

New research examines what drives, or hinders, pharmacists when guiding patients through self-medication decisions for minor ailments like cold and flu.

In an exploration of pharmacists’ self-efficacy, researchers explored medication counseling outcomes for older adults across various languages.

Cloned pharmacy sites and fake GLP-1 weight-loss pens surge online, prompting federal crackdowns and urgent safety warnings for patients.

FDA approves Idvynso, a 2-drug HIV switch option for suppressed adults, supporting simpler care as people age with HIV and manage multiple conditions.

Pharmacists cut through wound-care aisle confusion, explaining simple steps, moist healing, and when basic dressings beat pricey ointments.

Researchers conduct an exploration of e-prescription challenges and potential across pharmacies in Germany.

Sally Rafie, PharmD, BCPS, discusses current developments regarding access to the abortion pill and other notable events regarding women’s reproductive rights.

The executive order mandates national priority vouchers for psychedelic drugs that have received breakthrough therapy designations.

This episode highlights key DSCSA updates in 2026, T3 documentation going forward, and many more developments surrounding the law.

Low pneumococcal vaccine rates have potential to significantly impact a variety of at-risk populations, even groups of certain health care workers.

New IL‑33 antibody cuts chronic obstructive pulmonary disease flare-ups in phase 3 trials, showing benefit and safety.

A long-term trial shows oral orforglipron boosts A1C and weight loss with reassuring cardiovascular safety and simpler dosing for type 2 diabetes.

Practical pharmacy wound care tips include choosing modern dressings, spotting infection red flags, and knowing when to refer.

Pharmacists optimize insulin therapy, including basal and bolus dosing, missed-dose tips, continuous glucose monitoring insights, and affordability.

New research shows older adults vaccinate more when confident navigating their health care.

Researchers measure exactly how much pharmacist-provided care is being underbilled and what gaps mean for the future of reimbursement.

New 2026 guidance backs long-term obesity drugs, spotlighting GLP-1 benefits, side effects, and off-label risks pharmacists must navigate.

Through the lens of changes in medication adherence, researchers assessed differences in CVD-related emergency department visits and total cost of care.

The most common mistake pharmacists can make when promoting their new clinical service is not marketing it.